RESEARCHERS from the Centenary Institute in Sydney have demonstrated how an influenza A-based vaccine can be used to activate immune cells in the lungs, and in turn, help protect against tuberculosis (TB).
Australia is seen as a prime target for total eradication of the disease.
Published in Mucosal Immunolgy, the study is found at nature.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Sep 18
